A Randomised Controlled Trial of Magnetic Seizure Therapy in Major Depressive Disorder

磁癫痫疗法治疗重度抑郁症的随机对照试验

基本信息

  • 批准号:
    nhmrc : 1002574
  • 负责人:
  • 金额:
    $ 24.81万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    NHMRC Project Grants
  • 财政年份:
    2011
  • 资助国家:
    澳大利亚
  • 起止时间:
    2011-01-01 至 2013-12-31
  • 项目状态:
    已结题

项目摘要

Electroconvulsive therapy (ECT) is the only established treatment for a substantial sub-population of patients who fail to respond to other therapies. However, there are significant complications of ECT including memory related side-effects. The aim of this study is to evaluate the clinical efficacy of a new form of treatment for severe depression, magnetic seizure therapy, which appears to have a substantially reduced rate of cognitive side-effects.
电休克治疗(ECT)是对大量对其他治疗无效的患者唯一确定的治疗方法。然而,ECT也有明显的并发症,包括记忆相关的副作用。这项研究的目的是评估一种治疗严重抑郁症的新形式--磁惊厥疗法的临床疗效,该疗法似乎显著降低了认知副作用的发生率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

A/Pr Kate Hoy其他文献

A/Pr Kate Hoy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('A/Pr Kate Hoy', 18)}}的其他基金

DEVELOPMENT OF NOVEL THERAPEUTICS FOR DEMENTIA: Investigating tailored brain stimulation approaches for dementia prevention and treatment.
痴呆症新疗法的开发:研究用于预防和治疗痴呆症的定制脑刺激方法。
  • 批准号:
    nhmrc : GNT1135558
  • 财政年份:
    2017
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Boosting Dementia Research Initiative
DEVELOPMENT OF NOVEL THERAPEUTICS FOR DEMENTIA: Investigating tailored brain stimulation approaches for dementia prevention and treatment.
痴呆症新疗法的开发:研究用于预防和治疗痴呆症的定制脑刺激方法。
  • 批准号:
    nhmrc : 1135558
  • 财政年份:
    2017
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Targeted Calls
RESTORING COGNITIVE FUNCTION USING BRAIN STIMULATION: Investigating the neurobiological and neurocognitive effects of non-invasive brain stimulation in schizophrenia.
使用脑刺激恢复认知功能:研究非侵入性脑刺激对精神分裂症的神经生物学和神经认知影响。
  • 批准号:
    nhmrc : 1082894
  • 财政年份:
    2015
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Career Development Fellowships
Accelerated repetitive transcranial magnetic stimulation in the treatment of depression
加速重复经颅磁刺激治疗抑郁症
  • 批准号:
    nhmrc : 1041890
  • 财政年份:
    2013
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Project Grants
Magnetic Seizure Therapy:The Neural Correlates and Neurocognitive Outcomes of a Novel Therapeutic Approach to Depression
磁癫痫疗法:抑郁症新治疗方法的神经相关性和神经认知结果
  • 批准号:
    nhmrc : 546229
  • 财政年份:
    2009
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Early Career Fellowships

相似海外基金

Memory Reshaping for Depression: A Remote Digital Randomised Controlled Feasibility Trial
抑郁症记忆重塑:远程数字随机控制可行性试验
  • 批准号:
    MR/Y008545/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Research Grant
ExtraCECI: A cluster randomised controlled trial of community-based person-centred enhanced care for people with HIV/AIDS in Ghana
ExtraCECI:一项以社区为基础、以人为本的强化对加纳艾滋病毒/艾滋病患者护理的整群随机对照试验
  • 批准号:
    MR/Y019865/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Research Grant
Sedation Practice in Intensive Care Evaluation: Early Sedation with Dexmedetomidine in Older Ventilated Critically Ill Patients (SPICE-IV): A Randomised Double-Blind Placebo-Controlled Trial
重症监护评估中的镇静实践:老年通气危重患者早期使用右美托咪定镇静 (SPICE-IV):一项随机双盲安慰剂对照试验
  • 批准号:
    477888
  • 财政年份:
    2023
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Operating Grants
MICA: Can interferon gamma prevent infection in critically ill patients at highest risk? A phase II randomised controlled trial.
MICA:γ 干扰素能否预防高风险危重患者的感染?
  • 批准号:
    MR/X004929/1
  • 财政年份:
    2022
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Research Grant
Intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine plus dihydroartemisinin-piperaquine to reduce adverse pregnancy outcomes and prevent malaria in Papua New Guinea: a randomised controlled trial
在巴布亚新几内亚,用磺胺多辛-乙胺嘧啶加双氢青蒿素-哌喹对妊娠期进行间歇性预防治疗,以减少不良妊娠结局并预防疟疾:一项随机对照试验
  • 批准号:
    nhmrc : 2000780
  • 财政年份:
    2022
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Clinical Trials and Cohort Studies Grants
Personalized integrated COgnitive-Sensory-MOtor training(iCOSMO) intervention to improve arm and hand function after chronic stroke: a pilot randomised controlled trial
个性化综合认知-感觉-运动训练(iCOSMO)干预以改善慢性中风后手臂和手部功能:一项试点随机对照试验
  • 批准号:
    460604
  • 财政年份:
    2022
  • 资助金额:
    $ 24.81万
  • 项目类别:
Parent-Delivered Early Language Intervention for Children with Down Syndrome: A Randomised Controlled Feasibility Trial
家长对唐氏综合症儿童进行早期语言干预:随机对照可行性试验
  • 批准号:
    ES/V016946/1
  • 财政年份:
    2022
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Research Grant
A novel placebo-based intervention for migraine: Randomised controlled trial
一种新颖的基于安慰剂的偏头痛干预措施:随机对照试验
  • 批准号:
    474000
  • 财政年份:
    2022
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Fellowship Programs
Minimising bone mineral density loss in traumatic amputees: a randomised controlled feasibility trial
最大限度地减少创伤性截肢者的骨矿物质密度损失:一项随机对照可行性试验
  • 批准号:
    EP/X027155/1
  • 财政年份:
    2022
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Fellowship
A Phase III randomised placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine ("Ice") dependence
米氮平作为甲基苯丙胺(“冰毒”)依赖药物疗法的 III 期随机安慰剂对照试验
  • 批准号:
    nhmrc : 2000375
  • 财政年份:
    2021
  • 资助金额:
    $ 24.81万
  • 项目类别:
    Clinical Trials and Cohort Studies Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了